Navigation Links
BDSI secures US commercial partnership for BEMA Fentanyl with Meda AB
Date:9/5/2007

for us in the U.S. Our ambition with this product within the breakthrough cancer pain indication is to reach well over $200 million in yearly sales. Our U.S. marketing organization has good experience in the pain area and is well acquainted with the target group. Pain is a priority therapy area and with this deal we now add a significant potential for Meda in the U.S. market.


'/>"/>

Contact: Bill Douglass
bdouglass@investorrelationsgroup.com
212-825-3210
BioDelivery Sciences
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. TV drug commercials prompt prescriptions
2. Commercialization of Biotech Discoveries, An Encouragement For Researchers
3. A Move To Help Commercial Sex Workers Quit Their Business
4. Commercial grape juices and vinegars found rich in antioxidants
5. Widespread Commercialisation Of Human Organ Donation In China
6. Commercialization of drugs by fast tracking is a cause of concern
7. Formula milk suffering due to commercial interests
8. Spine Gourd Variety Helpful For Diabetics Is Ready For Commercial Cultivation
9. Updated Sleep Apnea Screening Recommended for Commercial Drivers
10. The Psyche Behind Drug Commercials
11. Magnets in Commercial Products may Cause a Fatal Attraction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...under Urges Youth to Become Organ Donors and Provi...swire-USNewswire/ -- Jeff Timmons, the founder of ...w Year,s Resolution for all of his fans - sign up ...life. , , (Photo: http://www.newscom.com/cgi...ebrity spokesperson for the newly formed Heather T...
(Date:1/8/2009)... Today, Compensation Professionals are asked ...same time, budgets for automation tools are beyond...ck solid business case citing real world results w...gement technology can pay for itself (and then som...acksonville, FL (PRWEB) January 8, 2009 -- HCR Sof...
(Date:1/8/2009)... Hall and Praeger to discuss potential Obama he...ty plans, the dangers of federal regulation, subsi... crowd and more. , Kansas...raeger, Insurance Commissioner for the state of Ka...pm CST, on Cary Hall,s Health Insurance Advocate ...
(Date:1/7/2009)..., Jan. 7 Non-profits Medical Tourism Association ...y Health Care City ( www.monterreyciudaddelasalu...st Latin America Medical Tourism and Health Touris...nterrey, Mexico at the Intercontinental Presidente...ns of medical tourism in Latin America, has severa...
Breaking Medicine News(10 mins):Health News:Jeff Timmons and the Heather Trew Foundation Join Forces to Promote Organ Donations 2Health News:Now, More Than Ever, Automating Compensation Planning Is A Good Financial Decision 2Health News:Now, More Than Ever, Automating Compensation Planning Is A Good Financial Decision 3Health News:Kansas Insurance Commissioner, Sandy Praeger, to Appear this Saturday on Cary Hall's Health Insurance Advocate Radio Show 2Health News:Kansas Insurance Commissioner, Sandy Praeger, to Appear this Saturday on Cary Hall's Health Insurance Advocate Radio Show 3Health News:The Non-Profits Medical Tourism Association (MTA), Monterrey Health Care City (MHCC) Have Partnered Together to Create the 1st Latin America Medical Tourism and Health Tourism Congress Which Occurs April 27-29th, 2009 in Monterrey, Mexico at the Intercont 2Health News:The Non-Profits Medical Tourism Association (MTA), Monterrey Health Care City (MHCC) Have Partnered Together to Create the 1st Latin America Medical Tourism and Health Tourism Congress Which Occurs April 27-29th, 2009 in Monterrey, Mexico at the Intercont 3Health News:The Non-Profits Medical Tourism Association (MTA), Monterrey Health Care City (MHCC) Have Partnered Together to Create the 1st Latin America Medical Tourism and Health Tourism Congress Which Occurs April 27-29th, 2009 in Monterrey, Mexico at the Intercont 4
...ts from the University of Adelaide, Monash Univers...rough in understanding how bacterial toxins cause/...s, led by Dr Adrienne Paton from the University of...omedical Science, have discovered that a highly po...
...discovered more than a century ago, triggering a r...ht more powerful ways to "see" into the human body...R. Oishei Foundation, researchers in the Universit...hotonics and Biophotonics are turning their expert...
...iliser Minister Ram Vilas Paswan promises a new po...ines, health insurance and subsidised treatment fo...ope to have drug banks operational at district hea...ree medication to the poor," Paswan said in an int...
...ety disorders and phobias are more common in women..., a new report from Harvard Medical School. Scient...rs, as well as differences in experiences, that ma...n are twice as likely to suffer from panic disorde...
Other Medicine News:Health News:Scientists Make World Breakthrough 2Health News:Hybrid Nanoparticles for Multimodal Medical Imaging 2Health News:Hybrid Nanoparticles for Multimodal Medical Imaging 3Health News:Free Medicines, Health Insurance for Poor Soon: Paswan 2
(Date:1/6/2009)..., Md., Jan. 6 Sequella,...focused on diseases of epidemic potential, announc...he treatment of tuberculosis (TB), was the first d...nical program contract to Dynport Vaccine Company ...rded by the National Institute of Allergy and Infe...
(Date:1/5/2009)...SDA, Md., Jan. 5 Microme...mpany developing novel, proprietary,antibodies fo...mune diseases,provides an outlook on key events ... intends to provide an update on its research and ..., -- April 12 to 16, 2009: Update on several p...
(Date:12/27/2008)...,S, Bermuda, Dec. 23 War...oday that one of its subsidiaries and Mayne Pharma...f Hospira, Inc., have filed lawsuits against each ... Mylan Pharmaceuticals Inc. ("Mylan") and Impax La...for the District of New Jersey for infringement of...
(Date:12/17/2008)...st, Most Complex of Its Kind; 80 Percent of Trauma... Dec. 17 A multi-disciplinary team...tly performed the first near-total face transplan...rocedure performed within the past two weeks, surg... suffered severe facial trauma -- essentially repl...
Breaking Medicine Technology:Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3Micromet Key Events for 2009 2Micromet Key Events for 2009 3Micromet Key Events for 2009 4Micromet Key Events for 2009 5Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent 2Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent 3Cleveland Clinic Surgeons Perform Nation's First Near-Total Face Transplant 2Cleveland Clinic Surgeons Perform Nation's First Near-Total Face Transplant 3FSU Historians Arctic research has him sitting on top of the world 5651 1FSU Historians Arctic research has him sitting on top of the world 5651 2FSU Historians Arctic research has him sitting on top of the world 5651 3Telik Announces Top Line Results From Assist 5 Trial of Telcyta 28R 29 in Combination With Pegylated Liposomal Doxorubicin in Platinum Refractory and 8718 1Telik Announces Top Line Results From Assist 5 Trial of Telcyta 28R 29 in Combination With Pegylated Liposomal Doxorubicin in Platinum Refractory and 8718 2Telik Announces Top Line Results From Assist 5 Trial of Telcyta 28R 29 in Combination With Pegylated Liposomal Doxorubicin in Platinum Refractory and 8718 3Telik Announces Top Line Results From Assist 5 Trial of Telcyta 28R 29 in Combination With Pegylated Liposomal Doxorubicin in Platinum Refractory and 8718 4Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 28174 1Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 28174 2Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 28174 3Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 28174 4Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 28174 5Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 28174 6Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 28174 7Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 28174 8Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 28174 9Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 28174 10Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 28174 11Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 28174 12XELR8 Holdings Announces Conference Call to Review Third Quarter Financial Results 28172 1XELR8 Holdings Announces Conference Call to Review Third Quarter Financial Results 28172 2
... Pending Final Analysis of the Results, ISTA Plans...-, IRVINE, Calif., May 31, 2007 /PRNewswire-FirstC...ed positive results from the,preliminary analysis ...t sodium, which is being developed as a treatment ...m group achieved a strong,trend in the objective s...
...EVERLY HILLS, Calif.--(BUSINESS WIRE)--May 31, 200...rom an online survey of Suboxone,users, indicating...uboxone, also known as Subutex or Buprenorphine, b...sistance, indicating a,physical dependency. Suboxo...tes including OxyContin, Vicodin, Lortab or,Fentan...
Other Medicine Technology:ISTA Pharmaceuticals Announces Positive Preliminary Results from,Ecabet Sodium Phase IIb Study 2ISTA Pharmaceuticals Announces Positive Preliminary Results from,Ecabet Sodium Phase IIb Study 3ISTA Pharmaceuticals Announces Positive Preliminary Results from,Ecabet Sodium Phase IIb Study 4ISTA Pharmaceuticals Announces Positive Preliminary Results from,Ecabet Sodium Phase IIb Study 5Waismann Method Survey Reveals Dependency Risk for People Using,Suboxone 2
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
Medicine Products: